-
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024
Huiberts, A. J., Hoeve, C. E., de Gier, B., Cremer, J., van der Veer, B., de Melker, H. E., van de Wijgert, J. H. H. M., van den Hof, S., Eggink, D. & Knol, M. J., 7 Mar 2024, In: Eurosurveillance. 29, 10, e2400109.Research output: Contribution to journal › Article › Academic › peer-review
-
Novel emm4 lineage associated with an upsurge in invasive group A streptococcal disease in the Netherlands, 2022
van der Putten, B. C. L., Bril-Keijzers, W. C. M., Rumke, L. W., Vestjens, S. M. T., Koster, L. A. M., Willemsen, M., van Houten, M. A., Rots, N. Y., Vlaminckx, B. J. M., de Gier, B. & van Sorge, N. M., 1 Jun 2023, In: Microbial genomics. 9, 6, 001026.Research output: Contribution to journal › Article › Academic › peer-review
-
Group A Streptococcal Meningitis with the M1UKVariant in the Netherlands
van der Putten, B. C. L., Vlaminckx, B. J. M., de Gier, B., Freudenburg-de Graaf, W. & van Sorge, N. M., 23 May 2023, In: JAMA. 329, 20, p. 1791-1792 2 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
